{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:44:45Z","timestamp":1792593885138,"version":"4.5.0"},"reference-count":26,"publisher":"MyJove Corporation","issue":"223","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68947","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:01:11Z","timestamp":1759273271000},"source":"Crossref","is-referenced-by-count":0,"title":["High-Density Lipoprotein-Specific Phospholipid Efflux Assay"],"prefix":"10.3791","author":[{"given":"Edward B.","family":"Neufeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"ref1","type":"book","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume-title":"Circulation","author":"Grundy","year":"2019","unstructured":"Grundy, S. M. et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 139 (25), e1082-e1143 (2019)."},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI118751","type":"journal-article","article-title":"Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels","volume":"97","author":"Zhong","year":"1996","unstructured":"Zhong, S. et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97 (12), 2917-2923 (1996).","journal-title":"J Clin Invest"},{"issue":"32","key":"ref3","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","type":"journal-article","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","unstructured":"Madsen, C. M., Varbo, A., Nordestgaard, B. G. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies. Eur Heart J. 38 (32), 2478-2486 (2017).","journal-title":"Eur Heart J"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","type":"journal-article","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The CANHEART study","volume":"68","author":"Ko","year":"2016","unstructured":"Ko, D. T. et al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The CANHEART study. J Am Coll Cardiol. 68 (19), 2073-2083 (2016).","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","type":"journal-article","article-title":"Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study","volume":"249","author":"Liu","year":"2016","unstructured":"Liu, C. et al. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study. Atherosclerosis. 249, 116-124 (2016).","journal-title":"Atherosclerosis"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","type":"journal-article","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","unstructured":"Rosenson, R. S. et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 13 (1), 48-60 (2016).","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","type":"journal-article","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","unstructured":"Khera, A. V. et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 364 (2), 127-135 (2011).","journal-title":"N Engl J Med"},{"issue":"25","key":"ref8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","type":"journal-article","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","unstructured":"Rohatgi, A. et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 371 (25), 2383-2393 (2014).","journal-title":"N Engl J Med"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","type":"journal-article","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using bodipy-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","unstructured":"Sankaranarayanan, S. et al. A sensitive assay for ABCA1-mediated cholesterol efflux using bodipy-cholesterol. Journal of Lipid Research. 52 (12), 2332-2340 (2011).","journal-title":"Journal of Lipid Research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.jlr.2021.100125","type":"journal-article","article-title":"Lysis reagents, cell numbers, and calculation method influence high-throughput measurement of HDL-mediated cholesterol efflux capacity","volume":"62","author":"Schachtl-Riess","year":"2021","unstructured":"Schachtl-Riess, J. F. et al. Lysis reagents, cell numbers, and calculation method influence high-throughput measurement of HDL-mediated cholesterol efflux capacity. J Lipid Res. 62, 100125 (2021).","journal-title":"J Lipid Res"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1373\/jalm.2016.022913","type":"journal-article","article-title":"Cholesterol uptake capacity: A new measure of HDL functionality for coronary risk assessment","volume":"2","author":"Harada","year":"2017","unstructured":"Harada, A. et al. Cholesterol uptake capacity: A new measure of HDL functionality for coronary risk assessment. J Appl Lab Med. 2 (2), 186-200 (2017).","journal-title":"J Appl Lab Med"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"BSR20180144","DOI":"10.1042\/BSR20180144","type":"journal-article","article-title":"Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells","volume":"38","author":"Horiuchi","year":"2018","unstructured":"Horiuchi, Y. et al. Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells. Biosci Rep. 38 (2), BSR20180144 (2018).","journal-title":"Biosci Rep"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jalm\/jfaa002","type":"journal-article","article-title":"A novel cell-free fluorescent assay for HDL function: Low apolipoprotein a1 exchange rate associated with increased incident cardiovascular events","volume":"5","author":"Lorkowski","year":"2020","unstructured":"Lorkowski, S. W. et al. A novel cell-free fluorescent assay for HDL function: Low apolipoprotein a1 exchange rate associated with increased incident cardiovascular events. J Appl Lab Med. 5 (3), 544-557 (2020).","journal-title":"J Appl Lab Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/qjmed\/hcad251","type":"journal-article","article-title":"Rethinking 'good cholesterol' for cardiovascular risk stratification","volume":"117","author":"Denimal","year":"2023","unstructured":"Denimal, D. Rethinking 'good cholesterol' for cardiovascular risk stratification. QJM: An Int J Med. 117 (4), 243-245 (2023).","journal-title":"QJM: An Int J Med"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1194\/jlr.M059865","type":"journal-article","article-title":"HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity","volume":"56","author":"Borja","year":"2015","unstructured":"Borja, M. S. et al. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res. 56 (10), 2002-2009 (2015).","journal-title":"J Lipid Res"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"e71541","DOI":"10.1371\/journal.pone.0071541","type":"journal-article","article-title":"HDL-apoa-I exchange: Rapid detection and association with atherosclerosis","volume":"8","author":"Borja","year":"2013","unstructured":"Borja, M. S. et al. HDL-apoa-I exchange: Rapid detection and association with atherosclerosis. PLoS One. 8 (8), e71541 (2013).","journal-title":"PLoS One"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1006\/bbrc.2000.4219","type":"journal-article","article-title":"Apolipoprotein specificity for lipid efflux by the human ABCAI transporter","volume":"280","author":"Remaley","year":"2001","unstructured":"Remaley, A. T. et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun. 280 (3), 818-823 (2001).","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"ref18","doi-asserted-by":"crossref","first-page":"e165370","DOI":"10.1172\/JCI165370","type":"journal-article","article-title":"Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease","volume":"133","author":"Sato","year":"2023","unstructured":"Sato, M. et al. Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. J Clin Invest. 133 (18), e165370 (2023).","journal-title":"J Clin Invest"},{"issue":"3","key":"ref19","first-page":"53","type":"journal-article","article-title":"ApoA-I-mediated lipoprotein remodeling monitored with a fluorescent phospholipid","volume":"8","author":"Neufeld","year":"2019","unstructured":"Neufeld, E. B. et al. ApoA-I-mediated lipoprotein remodeling monitored with a fluorescent phospholipid. Biology (Basel). 8 (3), 53 (2019).","journal-title":"Biology (Basel)"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1194\/jlr.M066613","type":"journal-article","article-title":"The effects of apolipoprotein B depletion on HDL subspecies composition and function","volume":"57","author":"Davidson","year":"2016","unstructured":"Davidson, W. S. et al. The effects of apolipoprotein B depletion on HDL subspecies composition and function. J Lipid Res. 57 (4), 674-686 (2016).","journal-title":"J Lipid Res"},{"issue":"35","key":"ref21","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","type":"journal-article","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","unstructured":"Phillips, M. C. Molecular mechanisms of cellular cholesterol efflux. J Biol Chem. 289 (35), 24020-24029 (2014).","journal-title":"J Biol Chem"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0022-2275(20)37453-8","type":"journal-article","article-title":"Apolipoprotein-mediated removal of cellular cholesterol and phospholipids","volume":"37","author":"Oram","year":"1996","unstructured":"Oram, J. F., Yokoyama, S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 37 (12), 2473-2491 (1996).","journal-title":"J Lipid Res"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1194\/jlr.R082313","type":"journal-article","article-title":"Is ABCA1 a lipid transfer protein","volume":"59","author":"Phillips","year":"2018","unstructured":"Phillips, M. C. Is ABCA1 a lipid transfer protein? Journal of Lipid Research. 59 (5), 749-763 (2018).","journal-title":"Journal of Lipid Research"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1194\/jlr.M300336-JLR200","type":"journal-article","article-title":"Abca1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I","volume":"45","author":"Smith","year":"2004","unstructured":"Smith, J. D. et al. Abca1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res. 45 (4), 635-644 (2004).","journal-title":"J Lipid Res"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"e0150083","DOI":"10.1371\/journal.pone.0150083","type":"journal-article","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","unstructured":"Ossoli, A. et al. Lipoprotein X causes renal disease in LCAT deficiency. PLoS One. 11 (2), e0150083 (2016).","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.70223","type":"journal-article","article-title":"Effect of extra virgin olive oil high in bioactive compounds on atherosclerosis in apoe-deficient mice","author":"Mart\u00ednez-Beamonte","year":"2025","unstructured":"Mart\u00ednez-Beamonte, R. et al. Effect of extra virgin olive oil high in bioactive compounds on atherosclerosis in apoe-deficient mice. Mol Nutr Food Res. (2025).","journal-title":"Mol Nutr Food Res"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68947\/high-density-lipoprotein-specific-phospholipid-efflux-assay","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:27:57Z","timestamp":1792592877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68947\/high-density-lipoprotein-specific-phospholipid-efflux-assay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":26,"journal-issue":{"issue":"223","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68947","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}